Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells

Malignant mesothelioma (MM) is an aggressive cancer, characterized by rapid progression, along with late metastasis and poor patient prognosis. It is resistant to many forms of standard anti-cancer treatment. In this study, we determined the effect of secreted frizzled-related protein 4 (sFRP4), a W...

Full description

Bibliographic Details
Main Authors: Perumal, Vanathi, Pohl, S., Keane, K., Arfuso, Frank, Newsholme, Philip, Fox, Simon, Dharmarajan, Arun
Format: Journal Article
Published: 2015
Online Access:http://hdl.handle.net/20.500.11937/30545
_version_ 1848753119057412096
author Perumal, Vanathi
Pohl, S.
Keane, K.
Arfuso, Frank
Newsholme, Philip
Fox, Simon
Dharmarajan, Arun
author_facet Perumal, Vanathi
Pohl, S.
Keane, K.
Arfuso, Frank
Newsholme, Philip
Fox, Simon
Dharmarajan, Arun
author_sort Perumal, Vanathi
building Curtin Institutional Repository
collection Online Access
description Malignant mesothelioma (MM) is an aggressive cancer, characterized by rapid progression, along with late metastasis and poor patient prognosis. It is resistant to many forms of standard anti-cancer treatment. In this study, we determined the effect of secreted frizzled-related protein 4 (sFRP4), a Wnt pathway inhibitor, on cancer cell proliferation and metabolism using the JU77 mesothelioma cell line.Treatment with sFRP4 (250. pg/ml) resulted in a significant reduction of cell proliferation. The addition of the Wnt activator Wnt3a (250. pg/ml) or sFRP4 had no significant effect on ATP production and glucose utilisation in JU77 cells at both the 24 and 48. h time points examined. We also examined their effect on Akt and Glycogen synthase kinase-3 beta (GSK3ß) phosphorylation, which are both important components of Wnt signalling and glucose metabolism. We found that protein phosphorylation of Akt and GSK3ß varied over the 24. h and 48. h time points, with constitutive phosphorylation of Akt at serine 473 (pAkt) decreasing to its most significant level when treated with Wnt3a+sFRP4 at the 24. h time point. A significant reduction in the level of Cytochrome c oxidase was observed at the 48. h time point, when sFRP4 and Wnt3a were added in combination.We conclude that sFRP4 may function, in part, to reduce/alter cancer cell metabolism, which may lead to sensitisation of cancer cells to chemotherapeutics, or even cell death.
first_indexed 2025-11-14T08:19:26Z
format Journal Article
id curtin-20.500.11937-30545
institution Curtin University Malaysia
institution_category Local University
last_indexed 2025-11-14T08:19:26Z
publishDate 2015
recordtype eprints
repository_type Digital Repository
spelling curtin-20.500.11937-305452017-09-13T15:33:14Z Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells Perumal, Vanathi Pohl, S. Keane, K. Arfuso, Frank Newsholme, Philip Fox, Simon Dharmarajan, Arun Malignant mesothelioma (MM) is an aggressive cancer, characterized by rapid progression, along with late metastasis and poor patient prognosis. It is resistant to many forms of standard anti-cancer treatment. In this study, we determined the effect of secreted frizzled-related protein 4 (sFRP4), a Wnt pathway inhibitor, on cancer cell proliferation and metabolism using the JU77 mesothelioma cell line.Treatment with sFRP4 (250. pg/ml) resulted in a significant reduction of cell proliferation. The addition of the Wnt activator Wnt3a (250. pg/ml) or sFRP4 had no significant effect on ATP production and glucose utilisation in JU77 cells at both the 24 and 48. h time points examined. We also examined their effect on Akt and Glycogen synthase kinase-3 beta (GSK3ß) phosphorylation, which are both important components of Wnt signalling and glucose metabolism. We found that protein phosphorylation of Akt and GSK3ß varied over the 24. h and 48. h time points, with constitutive phosphorylation of Akt at serine 473 (pAkt) decreasing to its most significant level when treated with Wnt3a+sFRP4 at the 24. h time point. A significant reduction in the level of Cytochrome c oxidase was observed at the 48. h time point, when sFRP4 and Wnt3a were added in combination.We conclude that sFRP4 may function, in part, to reduce/alter cancer cell metabolism, which may lead to sensitisation of cancer cells to chemotherapeutics, or even cell death. 2015 Journal Article http://hdl.handle.net/20.500.11937/30545 10.1016/j.yexcr.2016.02.008 restricted
spellingShingle Perumal, Vanathi
Pohl, S.
Keane, K.
Arfuso, Frank
Newsholme, Philip
Fox, Simon
Dharmarajan, Arun
Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
title Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
title_full Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
title_fullStr Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
title_full_unstemmed Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
title_short Therapeutic approach to target mesothelioma cancer cells using the Wnt antagonist, secreted frizzled-related protein 4: Metabolic state of cancer cells
title_sort therapeutic approach to target mesothelioma cancer cells using the wnt antagonist, secreted frizzled-related protein 4: metabolic state of cancer cells
url http://hdl.handle.net/20.500.11937/30545